Trial ID | Intervention(s) (route, frequency, total dose/day) | Intervention(s) appropriate as applied in a clinical practice settinga | Comparator(s) (route, frequency, total dose/day) | Comparator(s) appropriate as applied in a clinical practice settinga |
Alfawaz 2018 | Metformin 500 mg twice a day plus standard advice on diet plus exercise | Yes | C1: intensive diet and exercise | Yes |
C2: diet plus exercise | ||||
PREVENT‐DM 2017 | Metformin 850 mg daily for the first month, thereafter 850 mg twice daily. If side effects, then dose reduction. Titrated to the highest tolerable dose with a maximum of 850 mg three times a day | Yes | C1: intensive diet and physical activity | Yes |
C2: diet plus exercise | ||||
Zeng 2013 | Metformin 38 mg once daily. Diet plus exercise (no details) |
Yes | C1: diet plus exercise | Yes |
C2: pioglitazone 38 mg once daily Diet plus exercise | ||||
Zhao 2013 | Metformin 500 mg twice daily Education plus behaviour interventions, including diet control and increased physical activity (at least 30 minutes per day and at least 5 days per week) |
Yes | Education plus behaviour interventions, including diet control and increased physical activity (at least 30 minutes per day and at least 5 days per week) | Yes |
Iqbal Hydrie 2012 | Metformin 500 mg twice daily plus intensive diet and physical activity | Yes | C1: intensive diet plus physical activity | Yes |
C2: standard medical advice | ||||
Liao 2012 | Metformin from 250 mg, three times daily, adjusting the dose according to blood glucose, with the maximum 1500 mg daily | Yes | Acarbose from 50 mg three times daily with meals, adjusting the dose according to blood glucose, with the maximum 300 mg daily | Yes |
Ji 2011 | Metformin 500 mg, three times daily, after meals. Standard advice on diet plus exercise |
Yes | C1: Intesive diet plus exercise; based on individual dietary habits, calories are determined according to age, height, actual weight, activity intensity and season. Patients were given a low‐fat diet and a controlled diet. Patients were instructed to have a balanced diet and exercise (150 minutes per week). | Yes |
C2: diet plus exercise | ||||
Lu 2010 | Metformin 250 mg three times daily, according to tolerance, gradually reaching the target dose of 500 mg three times daily Lectures and leaflets were given to inform the prognosis and hazards of pre‐diabetes, and scientific diet and exercise instructions were provided for each follow‐up to promote a healthy lifestyle |
Yes | By giving lectures and sending out leaflets to inform the prognosis and hazards of pre‐diabetes, providing healthy diet and lifestyle guidance, referring to the dietary nutrition guidelines of China, and adjusting diet according to individual specific conditions to maintain a balanced nutritional status. The advice was: (1) variety of food, mainly cereals, with a combination of grains and grains; (2) eat more vegetables, fruits and potatoes; (3) daily intake of milk, beans and their preparation; (4) eat adequate amount of fish, poultry, eggs and lean meat; (5) reduce the amount of cooking oil, eat light diet with little salt, not too greasy and salty, including not too much smoke and animal oil food, daily adult salt to 6 g, eat less pickles, monosodium glutamate and other sodium‐containing food; (6) reasonable allocation of three meals, snacks should be appropriate. Reduce calorie intake to maintain the ideal weight. Patients with a BMI < 25kg/m2 were advised 30 Kcal/kg·day, with emphasis on alcohol and sugary soft drinks: patients with a BMI ≥ 25kg/m2 were encouraged to lose 0.5 g to 1.0 kg per month until ideal body weight. Initiate, encourage family members to care, supervise the completion of dietary plan. At each follow‐up, the participants were informed of dietary compliance. The exercise advice was as follows: (1) exercise prescription should consider the patient's individual factors such as gender, age, height, weight and living habits comprehensively; (2) principle of gradual progress and acting according to ability.The formulation of exercise prescription should be based on the patient's disease degree, physical condition to develop a long‐term plan, step by step, not subjective assumptions, eager for quick success and instant benefit. In the exercise prescription a clear purpose should be stated, and use the degree of realisation of this purpose to measure and modify the exercise prescription. Patients are required to engage in continuous aerobic exercise. Generally, after 30 minutes of exercise, blood glucose starts to supply energy to tissues, thus causing a drop in blood glucose. Moreover, studies have confirmed that the effect of moderate amount of exercise on blood glucose lasts for 12 months.17 hours, so people with diabetes should exercise at least once a day, no less than 30 minutes at a time. According to the principles and contents of exercise prescription, the exercise group should take appropriate physical activities and adopt various forms according to the specific conditions of each person, such as walking, jogging, playing ball games, aerobics, taijiquan, etc. It is required that the exercise program should be 1 exercise unit per day, lasting at least 30 minutes, and at least 5 days per week. At each follow‐up, participants were informed about exercise compliance and urged to stick to the prescribed exercise regimen. |
Yes |
BIGPRO1 2009 | Metformin, 850 mg tablet twice a day; diet plus exercise | Yes | Identical placebo tablet given twice a day; diet plus exercise | Yes |
Chen 2009 | Metformin 750 mg, three times daily All patients received behaviour changing with reference to diet and exercise therapy in the diabetes guidelines of China |
Yes | All patients received behaviour changing with reference to diet and exercise therapy in the diabetes guidelines of China. | Yes |
Jin 2009 | Metformin 1000 mg twice or three times daily. Diet plus exercise (no details) |
Yes | C1: diet plus exercise (no details) | Yes |
C2: rosiglitazone 4 mg, orally, once daily. Diet plus exercise (no details) | ||||
Li 2009 | Metformin 500 mg once daily plus diet and exercise | Yes | Individualised diet and exercise and education | Yes |
Wang 2009 | Metformin 250 mg twice daily, with or after meals. Plus standard advice on diet and exercise |
Yes | Diet plus exercise | Yes |
IDPP‐1 2006 | I1: Metformin, 500 mg twice a day I2: Metformin, 500 mg twice a day plus intensive diet and physical activity |
Yes | C1: intensive diet and exercise | Yes |
C2: standard care | ||||
Maji 2005 | Metformin 500 mg once daily plus diet and physical activity | Yes | C1: intensive diet and physical activity | Yes |
C2: rosiglitazone 2 mg daily plus diet and physical activity | ||||
C3: acarbose 25 mg twice daily plus diet and physical activity | ||||
Fang 2004 | Metformin 375 mg to 750 mg three times a day | Yes | C1: acarbose 75 mg to 150 mg three times a day | Yes |
C2: intensive diet plus exercise | ||||
C3: diet and physical activity | ||||
DPP/DPPOS 2002 | Metformin 850 mg twice a day plus standard diet and lifestyle advice | Yes | C1: intensive diet plus exercise: consumption of a healthy low‐calorie, low‐fat diet and to engage in physical activity of moderate intensity (such as brisk walking) for at least 150 minutes/week | Yes |
C2: placebo tablets given twice a day plus standard diet and lifestyle advice | ||||
Lu 2002 | Metformin 750 mg three times daily. Health education (not described, assumed to be standard care) |
Yes | C1: health education (not described, assumed to be standard care) | Yes |
C2: diet instruction (every 6 months). Health education | ||||
C3: fibre diet, fibre (Litesse) 6 g, twice daily, take with meal. Provide fibre once a month. Health education | ||||
Li 1999 | Metformin, 250 mg three times a day | Yes | C1: placebo administered with the same schedule as metformin | Yes |
Papoz 1978 | Metformin 850 mg, twice daily plus placebo, twice daily; overweight participants were recommended calorie restriction | Yes | C1: glibenclamide 2.0 mg, orally, twice daily and placebo, orally, twice daily. Overweight participants were recommended calorie restriction | Yes |
C2: placebo, orally, twice daily; overweight participants were recommended calorie restriction | ||||
aThe term 'clinical practice setting' refers to the specification of the intervention/comparator as used in the course of a standard medical treatment (such as dose, dose escalation, dosing scheme, provision for contraindications and other important features) BMI: body mass index; C: comparator; I: intervention. |